INVIVOGEN

Company Overview

InvivoGen is a life science reagent company that supplies preclinical-grade immunology tools for evaluating and optimizing vaccine adjuvant performance. It offers a broad portfolio spanning particulate adjuvants and emulsion systems as well as defined immunostimulants that target innate immune pathways (e.g., PRR/STING/TLR signaling), supporting antigen–adjuvant screening and mechanism-of-action studies in infectious disease and oncology vaccination research.

InvivoGen aligns with the vaccine adjuvants market through its focus on standardized, sterile, and research-use adjuvant reagents and related vaccination tools (including antigen–adjuvant conjugation concepts) that enable reproducible formulation work and comparative testing across candidate adjuvant classes.

Company's Business Segments

• Products : Cell Culture, Cell Lines, PRR Ligands, Inhibitors, Antibodies and ELISAs, Vaccine Adjuvants, Proteins, Cloning and Expression, Genes and Promoters.
• Services : PRR Ligand Screening, Custom Cloning.